COVID-19 Impact on Global Cell-based Assays Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cell-based Assays Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Cell-based Assays Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Consumables
  • 1.4.3 Instruments
  • 1.4.4 Services
  • 1.4.5 Software
• 1.5 Market by Application
  • 1.5.1 Global Cell-based Assays Market Share by Application: 2020 VS 2026
  • 1.5.2 Pharmaceutical & Biotechnology Companies
  • 1.5.3 Academic & Government Institutions
  • 1.5.4 Other
• 1.6 Coronavirus Disease 2019 (Covid-19): Cell-based Assays Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Cell-based Assays Industry
    • 1.6.1.1 Cell-based Assays Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Cell-based Assays Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Cell-based Assays Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Cell-based Assays Market Perspective (2015-2026)
• 2.2 Cell-based Assays Growth Trends by Regions
  • 2.2.1 Cell-based Assays Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cell-based Assays Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cell-based Assays Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cell-based Assays Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cell-based Assays Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cell-based Assays Players by Market Size
  • 3.1.1 Global Top Cell-based Assays Players by Revenue (2015-2020)
  • 3.1.2 Global Cell-based Assays Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cell-based Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cell-based Assays Market Concentration Ratio
  • 3.2.1 Global Cell-based Assays Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cell-based Assays Revenue in 2019
• 3.3 Cell-based Assays Key Players Head office and Area Served
• 3.4 Key Players Cell-based Assays Product Solution and Service
• 3.5 Date of Enter into Cell-based Assays Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Cell-based Assays Historic Market Size by Type (2015-2020)
• 4.2 Global Cell-based Assays Forecasted Market Size by Type (2021-2026)

5 Cell-based Assays Breakdown Data by Application (2015-2026)

• 5.1 Global Cell-based Assays Market Size by Application (2015-2020)
• 5.2 Global Cell-based Assays Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cell-based Assays Market Size (2015-2020)
• 6.2 Cell-based Assays Key Players in North America (2019-2020)
• 6.3 North America Cell-based Assays Market Size by Type (2015-2020)
• 6.4 North America Cell-based Assays Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cell-based Assays Market Size (2015-2020)
• 7.2 Cell-based Assays Key Players in Europe (2019-2020)
• 7.3 Europe Cell-based Assays Market Size by Type (2015-2020)
• 7.4 Europe Cell-based Assays Market Size by Application (2015-2020)

8 China

• 8.1 China Cell-based Assays Market Size (2015-2020)
• 8.2 Cell-based Assays Key Players in China (2019-2020)
• 8.3 China Cell-based Assays Market Size by Type (2015-2020)
• 8.4 China Cell-based Assays Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cell-based Assays Market Size (2015-2020)
• 9.2 Cell-based Assays Key Players in Japan (2019-2020)
• 9.3 Japan Cell-based Assays Market Size by Type (2015-2020)
• 9.4 Japan Cell-based Assays Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cell-based Assays Market Size (2015-2020)
• 10.2 Cell-based Assays Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cell-based Assays Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cell-based Assays Market Size by Application (2015-2020)

11 India

• 11.1 India Cell-based Assays Market Size (2015-2020)
• 11.2 Cell-based Assays Key Players in India (2019-2020)
• 11.3 India Cell-based Assays Market Size by Type (2015-2020)
• 11.4 India Cell-based Assays Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cell-based Assays Market Size (2015-2020)
• 12.2 Cell-based Assays Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cell-based Assays Market Size by Type (2015-2020)
• 12.4 Central & South America Cell-based Assays Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 BD Medical (US)
  • 13.1.1 BD Medical (US) Company Details
  • 13.1.2 BD Medical (US) Business Overview and Its Total Revenue
  • 13.1.3 BD Medical (US) Cell-based Assays Introduction
  • 13.1.4 BD Medical (US) Revenue in Cell-based Assays Business (2015-2020))
  • 13.1.5 BD Medical (US) Recent Development
• 13.2 Danaher (US)
  • 13.2.1 Danaher (US) Company Details
  • 13.2.2 Danaher (US) Business Overview and Its Total Revenue
  • 13.2.3 Danaher (US) Cell-based Assays Introduction
  • 13.2.4 Danaher (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.2.5 Danaher (US) Recent Development
• 13.3 Thermo Fisher Scientific (US)
  • 13.3.1 Thermo Fisher Scientific (US) Company Details
  • 13.3.2 Thermo Fisher Scientific (US) Business Overview and Its Total Revenue
  • 13.3.3 Thermo Fisher Scientific (US) Cell-based Assays Introduction
  • 13.3.4 Thermo Fisher Scientific (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.3.5 Thermo Fisher Scientific (US) Recent Development
• 13.4 General Healthcare (UK)
  • 13.4.1 General Healthcare (UK) Company Details
  • 13.4.2 General Healthcare (UK) Business Overview and Its Total Revenue
  • 13.4.3 General Healthcare (UK) Cell-based Assays Introduction
  • 13.4.4 General Healthcare (UK) Revenue in Cell-based Assays Business (2015-2020)
  • 13.4.5 General Healthcare (UK) Recent Development
• 13.5 Merck KGaA (Germany)
  • 13.5.1 Merck KGaA (Germany) Company Details
  • 13.5.2 Merck KGaA (Germany) Business Overview and Its Total Revenue
  • 13.5.3 Merck KGaA (Germany) Cell-based Assays Introduction
  • 13.5.4 Merck KGaA (Germany) Revenue in Cell-based Assays Business (2015-2020)
  • 13.5.5 Merck KGaA (Germany) Recent Development
• 13.6 Perkinelmer (US)
  • 13.6.1 Perkinelmer (US) Company Details
  • 13.6.2 Perkinelmer (US) Business Overview and Its Total Revenue
  • 13.6.3 Perkinelmer (US) Cell-based Assays Introduction
  • 13.6.4 Perkinelmer (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.6.5 Perkinelmer (US) Recent Development
• 13.7 Charles River Laboratories (US)
  • 13.7.1 Charles River Laboratories (US) Company Details
  • 13.7.2 Charles River Laboratories (US) Business Overview and Its Total Revenue
  • 13.7.3 Charles River Laboratories (US) Cell-based Assays Introduction
  • 13.7.4 Charles River Laboratories (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.7.5 Charles River Laboratories (US) Recent Development
• 13.8 Life Technologies (US)
  • 13.8.1 Life Technologies (US) Company Details
  • 13.8.2 Life Technologies (US) Business Overview and Its Total Revenue
  • 13.8.3 Life Technologies (US) Cell-based Assays Introduction
  • 13.8.4 Life Technologies (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.8.5 Life Technologies (US) Recent Development
• 13.9 Lonza Group (Switzerland)
  • 13.9.1 Lonza Group (Switzerland) Company Details
  • 13.9.2 Lonza Group (Switzerland) Business Overview and Its Total Revenue
  • 13.9.3 Lonza Group (Switzerland) Cell-based Assays Introduction
  • 13.9.4 Lonza Group (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  • 13.9.5 Lonza Group (Switzerland) Recent Development
• 13.10 Cell Signaling Technology (US)
  • 13.10.1 Cell Signaling Technology (US) Company Details
  • 13.10.2 Cell Signaling Technology (US) Business Overview and Its Total Revenue
  • 13.10.3 Cell Signaling Technology (US) Cell-based Assays Introduction
  • 13.10.4 Cell Signaling Technology (US) Revenue in Cell-based Assays Business (2015-2020)
  • 13.10.5 Cell Signaling Technology (US) Recent Development
• 13.11 Promega (US)
  • 10.11.1 Promega (US) Company Details
  • 10.11.2 Promega (US) Business Overview and Its Total Revenue
  • 10.11.3 Promega (US) Cell-based Assays Introduction
  • 10.11.4 Promega (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.11.5 Promega (US) Recent Development
• 13.12 Cisbio Bioassays (France)
  • 10.12.1 Cisbio Bioassays (France) Company Details
  • 10.12.2 Cisbio Bioassays (France) Business Overview and Its Total Revenue
  • 10.12.3 Cisbio Bioassays (France) Cell-based Assays Introduction
  • 10.12.4 Cisbio Bioassays (France) Revenue in Cell-based Assays Business (2015-2020)
  • 10.12.5 Cisbio Bioassays (France) Recent Development
• 13.13 Discoverx (US)
  • 10.13.1 Discoverx (US) Company Details
  • 10.13.2 Discoverx (US) Business Overview and Its Total Revenue
  • 10.13.3 Discoverx (US) Cell-based Assays Introduction
  • 10.13.4 Discoverx (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.13.5 Discoverx (US) Recent Development
• 13.14 Proqinase GmbH (Germany)
  • 10.14.1 Proqinase GmbH (Germany) Company Details
  • 10.14.2 Proqinase GmbH (Germany) Business Overview and Its Total Revenue
  • 10.14.3 Proqinase GmbH (Germany) Cell-based Assays Introduction
  • 10.14.4 Proqinase GmbH (Germany) Revenue in Cell-based Assays Business (2015-2020)
  • 10.14.5 Proqinase GmbH (Germany) Recent Development
• 13.15 Marine Biological Laboratory (US)
  • 10.15.1 Marine Biological Laboratory (US) Company Details
  • 10.15.2 Marine Biological Laboratory (US) Business Overview and Its Total Revenue
  • 10.15.3 Marine Biological Laboratory (US) Cell-based Assays Introduction
  • 10.15.4 Marine Biological Laboratory (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.15.5 Marine Biological Laboratory (US) Recent Development
• 13.16 Biospherix (US)
  • 10.16.1 Biospherix (US) Company Details
  • 10.16.2 Biospherix (US) Business Overview and Its Total Revenue
  • 10.16.3 Biospherix (US) Cell-based Assays Introduction
  • 10.16.4 Biospherix (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.16.5 Biospherix (US) Recent Development
• 13.17 Essen Bioscience (US)
  • 10.17.1 Essen Bioscience (US) Company Details
  • 10.17.2 Essen Bioscience (US) Business Overview and Its Total Revenue
  • 10.17.3 Essen Bioscience (US) Cell-based Assays Introduction
  • 10.17.4 Essen Bioscience (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.17.5 Essen Bioscience (US) Recent Development
• 13.18 Miltenyi Biotec (Switzerland)
  • 10.18.1 Miltenyi Biotec (Switzerland) Company Details
  • 10.18.2 Miltenyi Biotec (Switzerland) Business Overview and Its Total Revenue
  • 10.18.3 Miltenyi Biotec (Switzerland) Cell-based Assays Introduction
  • 10.18.4 Miltenyi Biotec (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  • 10.18.5 Miltenyi Biotec (Switzerland) Recent Development
• 13.19 Bioagilytix Labs (US)
  • 10.19.1 Bioagilytix Labs (US) Company Details
  • 10.19.2 Bioagilytix Labs (US) Business Overview and Its Total Revenue
  • 10.19.3 Bioagilytix Labs (US) Cell-based Assays Introduction
  • 10.19.4 Bioagilytix Labs (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.19.5 Bioagilytix Labs (US) Recent Development
• 13.20 Cell Biolabs (US)
  • 10.20.1 Cell Biolabs (US) Company Details
  • 10.20.2 Cell Biolabs (US) Business Overview and Its Total Revenue
  • 10.20.3 Cell Biolabs (US) Cell-based Assays Introduction
  • 10.20.4 Cell Biolabs (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.20.5 Cell Biolabs (US) Recent Development
• 13.21 Biotek Instruments (US)
  • 10.21.1 Biotek Instruments (US) Company Details
  • 10.21.2 Biotek Instruments (US) Business Overview and Its Total Revenue
  • 10.21.3 Biotek Instruments (US) Cell-based Assays Introduction
  • 10.21.4 Biotek Instruments (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.21.5 Biotek Instruments (US) Recent Development
• 13.22 Qgel SA (Switzerland)
  • 10.22.1 Qgel SA (Switzerland) Company Details
  • 10.22.2 Qgel SA (Switzerland) Business Overview and Its Total Revenue
  • 10.22.3 Qgel SA (Switzerland) Cell-based Assays Introduction
  • 10.22.4 Qgel SA (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  • 10.22.5 Qgel SA (Switzerland) Recent Development
• 13.23 Enzo Life Sciences (Switzerland)
  • 10.23.1 Enzo Life Sciences (Switzerland) Company Details
  • 10.23.2 Enzo Life Sciences (Switzerland) Business Overview and Its Total Revenue
  • 10.23.3 Enzo Life Sciences (Switzerland) Cell-based Assays Introduction
  • 10.23.4 Enzo Life Sciences (Switzerland) Revenue in Cell-based Assays Business (2015-2020)
  • 10.23.5 Enzo Life Sciences (Switzerland) Recent Development
• 13.24 Aurelia Bioscience (UK)
  • 10.24.1 Aurelia Bioscience (UK) Company Details
  • 10.24.2 Aurelia Bioscience (UK) Business Overview and Its Total Revenue
  • 10.24.3 Aurelia Bioscience (UK) Cell-based Assays Introduction
  • 10.24.4 Aurelia Bioscience (UK) Revenue in Cell-based Assays Business (2015-2020)
  • 10.24.5 Aurelia Bioscience (UK) Recent Development
• 13.25 Selexis SA (US)
  • 10.25.1 Selexis SA (US) Company Details
  • 10.25.2 Selexis SA (US) Business Overview and Its Total Revenue
  • 10.25.3 Selexis SA (US) Cell-based Assays Introduction
  • 10.25.4 Selexis SA (US) Revenue in Cell-based Assays Business (2015-2020)
  • 10.25.5 Selexis SA (US) Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer